Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Resistance and Futility

December 5, 2014 12:25 pm | by Elizabeth Cooney, Harvard Medical School | News | Comments

New findings reveal how penicillin deals bacteria a devastating blow. Read more...                              


Flu Vaccine May Be Less Effective This Winter

December 5, 2014 12:09 pm | by Mike Stobbe - AP Medical Writer | News | Comments

Officials say the vaccine does not protect well against the dominant strain seen most commonly so far this year. Read more...                       


GSK Cutting Hundreds of U.S. Jobs

December 5, 2014 12:02 pm | by Linda A. Johnson - AP Business Writer | News | Comments

Hundreds of British drugmaker GlaxoSmithKline's 17,000 U.S.-based employees will lose their jobs by the end of next year. Read more...                     


Takeda's Amyloidosis Inhibitor Gains Breakthrough Therapy Designation

December 5, 2014 10:13 am | News | Comments

Takeda's amyloidosis inhibitor was designated as a breakthrough therapy by the FDA. Read more...                            


Mylan Receives Tentative FDA Approval of HIV-1 Treatment

December 5, 2014 9:59 am | News | Comments

Mylan has received tentative FDA approval of its HIV-1 treatment for pediatric patients. Read more...                           


Building Personalized Approaches to Patient Care

December 5, 2014 9:43 am | by Jonathan Sheldon, PhD, global vice president, Oracle Health Sciences | Articles | Comments

With the evolution of electronic medical records (EMR) systems, and the integration of genomic data with multi-dimensional longitudinal clinical data, the opportunity is rife to build truly personalized approaches to patient care. 


Study Shows Serotonin Can Increase Risk of Drug Addiction

December 5, 2014 9:33 am | by Victoria University of Wellington | News | Comments

A new study shows that the development of drug addiction is related to brain levels of serotonin. Read more...                         


Retina Discovery Could Lead to New Cancer Treatments

December 5, 2014 9:19 am | by University of Adelaide | News | Comments

Eye surgeons have discovered that the retina in human eyes uses energy in a very similar way to cancer. Read more...                        


24 Go Blind After Cataract Surgery in India

December 5, 2014 9:06 am | by Chonchui Ngashangva - Associated Press | News | Comments

Authorities ordered an investigation Friday after at least 24 poor and elderly people went blind following cataract surgeries performed at a free medical camp run by a charity in northern India. Read more...         


Gene Discovery: How Stem Cells Can Help Immune System Fight Infection

December 4, 2014 10:38 am | News | Comments

In a study led by Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research member Dr. Julian Martinez-Agosto, UCLA scientists have shown that two genes not previously known to be involved with the immune system play a crucial role in how progenitor stem cells are activated to fight infection. Read more... 


Why Some Patients Respond to a Life-Saving Melanoma Drug

December 4, 2014 10:29 am | News | Comments

UCLA researchers have pioneered a new methodology to predict why some patients battling advanced melanoma respond well and others do not to the new breakthrough drug pembrolizumab. The study, led by UCLA Jonsson Comprehensive Cancer Center members Dr. Paul Tumeh and Dr. Antoni Ribas, primary investigator of pembrolizumab. Read more....


Patient Who May Have Ebola Arrives in Atlanta

December 4, 2014 9:52 am | by Jeff Martin - Associated Press | News | Comments

An American health-care worker who may have been infected with the Ebola virus in West Africa has arrived at a hospital near Atlanta. Emory University Hospital spokeswoman Holly Korschun says the patient arrived around 5:45 a.m. Thursday. Read More...


Vaximm Receives Positive Data from Oral Cancer Vaccine Trial

December 4, 2014 9:40 am | News | Comments

Vaximm AG, a Swiss-German biotech company focusing on oral cancer vaccines, announced follow-on data from the first clinical trial of its investigational oral T-cell vaccine VXM01. Data of a trial extension of the randomized, placebo-controlled, double-blind Phase 1 dose escalation study show that the safety profile to date is manageable.  Read More...


Array Regains Rights to Cancer Drug From Novartis

December 4, 2014 9:22 am | News | Comments

Array BioPharma Inc. announced that it has reached a definitive agreement with Novartis International Pharmaceutical Ltd. to regain full worldwide rights to binimetinib, a MEK inhibitor in three Phase 3 trials. Read more...                           


FDA Approves Amgen's ALL Treatment

December 3, 2014 5:10 pm | News | Comments

Amgen announced that the U.S. Food and Drug Administration (FDA) has granted approval of Blincyto (blinatumomab) for the treatment of patients with Philadelphia chromosome-negative (Ph-) relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.